Summary
Introduction
Brain AVMs are an important cause of haemorrhagic stroke and death in the population. Untreated AVMs bleed at an annual rate of 2-4 % although the risk may be as high as 6 % in the first year following a bleed 1-5 . The risk of death from a bleed has been estimated to be from 17 to 29 % and 23 to 38 % of survivors have a permanent disability 3, 6 . In a review of 115 patients, Hartmann et Al found a lower morbidity from initial bleeds with only 16% of patients being left with moderate or severe morbidity 7. Treatment strategies for small (<3 cm) AVMs have been a source of spirited controversy between advocates of surgery and radiosurgery (RS) 8.14 . Reports on embolisation have included predominantly larger AVMs and for most patients embolisation has been an adjunctive therapy followed by surgery or RS 15.20 . In this report our goal was to review our results of embolisation in small AVMs and test a proposed grading system based on the angioarchitecture that would predict percentage obliteration.
Material and Methods
We reviewed our clinical and imaging data on 80 consecutive patients with small brain AVMs who were treated by embolisation as part of the management strategy. The data were taken from our database of 674 patients with brain AVMs who have been assessed by our multi disciplinary team. The data were retrospectively gathered from 1984 to 1991 and prospectively collected from 1992 to 1999.
The cohort of 80 patients consisted of 41 males and 39 females ranging in age from 3 to 72 years (average age of 34.8 years). On presentation, 39 (49%) patients had haemorrhages, 32 (40%) had seizures, 4 (5 %) had a neurological deficit and five (6 %) were asymptomatic or had headaches. Thirty patients (38%) had neurological deficits at the time of embolisation. Embolisation was done in 81 small AVMs, in 80 patients. These 80 patients had a total of 99 embolisation sessions. Embolisation was the only treatment in 27 patients (28 AVMs), or done in combination with surgery in 20 patients, or in combination with RS in 30 patients. Three patients had a combination of embolisation, RS and surgery. Excluded from the analysis were patients with vein of Galen malformations and a single patient who had an embolisation with coils.
The locations of the AVMs are summarized in table 1. Forty-three were left sided, 30 right sided and eight were midline either corpus callosum (six AVMs) or cerebellar vermis (two AVMs). Fifteen (19%) of 81 AVMs were Spetzler-Martin grade I, 35 (44 %) were grade Il and 31 (39%) were grade Ill. Fourteen patients had 16 aneurysms: ten were pre-nidal, five were intra-nidal, and one was remote. One patient with Osler-Weber-Rendu disease had two sepa-R. Willinsky rate arteriovenous fistulas (AVFs) treated by embolisation.
The goal of embolisation for each patient was available from the database and was categorized as follows: cure in 27 AVMs, pre-surgical in 23 AVMs, pre-radiosurgery in 26 AVMs and elimination of an aneurysm in five AVMs. The pre-radiosurgery embolisations were done for size reduction since the chance of cure by radiosurgery increases as the AVM size decreases. Three of the five patients who were embolised to occlude an aneurysm went on to surgery to treat the AVM.
All AVMs were given a score based on features of their angioarchitecture. The score was based on the size of the nidus, the number of feeding arteries, the presence of feeding perforating arteries and the number of draining veins (table 2) . We established this grading system to determine its predictive value in embolisation. The assigned scores were as follows : nidus (fistula = 0, < 1 cm = 1,1-3 cm = 2), type of feeding arteries (cortical = 0, perforator or choroidal = 1), number of feeding arteries (single= 0, multiple= 2) and number of draining veins (single = 0, multiple = 1). The weighting of the score for the number of feeding arteries was based on an analysis of previous reports on embolisation 15 .1 6 • These reports had suggested that as the number of feeding arteries increased the percentage of angiographic obliteration decreased. For analysis the angioarchitecture scores were totaled and separated into three categories: 0-2, 3-4 and 5-6.
The angiographic results based on follow-up angiograms were grouped into three categories: complete obliteration, 66-99% obliteration and 0-65% obliteration. In 67 AVMs the results were based on angiograms done between two months and five years after embolisation. In the remaining 14 AVMs the results were based on angiograms done immediately following the embolisation. These angiographic results were correlated to the angioarchitecture scores (table 3) . These correlations were statistically analyzed using Fisher's exact test (twotailed) . The relationship between angiographic results and the individual features of the angioarchitecture were also reviewed ( In the last few years when concentration of the lipiodol was greater than 50% tantalum was not added. The patients were given dexamethasone (8 mgm three times daily for 2 days) beginning at the time of the procedure.
Results
Embolisation achieved complete anglOgraphic obliteration in 22 (27%) of the 81 AVMs. Follow-up angiography, from two months to five years later, confirmed the obliteration in 19 of the 22 AVMs (table 3). In three of the 22 AVMs complete obliteration was evident at the time of the embolisation but followup angiography was not done. Nine of the 22 AVMs had residual shunting immediately after embolisation but the follow-up angiogram showed complete occlusion. In the 27 AVMs where the goal of embolisation was cure, 19 (70%) were completely obliterated and six (22 %) had 66-99 % obliteration. Table 5 shows the number of cures in relation to SpetzlerMartin grades. Embolisation was successful in all five patients who were embolised to eliminate prenidal aneurysms.
Five patients had partial obliteration by embolisation and no further treatment. Two had bled and their prenidal aneurysms were occludInterventional Neuroradiology 7: [19] [20] [21] [22] [23] [24] [25] [26] [27] 2001 ed. Both were in their eighth decade of life and no further treatment was advised. Three patients were reluctant to proceed with further treatment.
In the AVMs with angioarchitecture scores of 0-2, 12 (86%) of 14 were cured (table 3). In the 23 AVMs with angioarchitecture scores of 3-4, eight (34 %) were cured, five (22 %) were 66-99% obliterated and ten (43%) were 0-65% obliterated. In the 44 AVMs with angioarchitecture scores of 5-6, two (4 %) were cured, ten (23 %) were 66-99% obliterated and 32 (73 %) were 0-65 % obliterated. The correlation between the angiographic scores and the angiographic obliteration achieved by embolisation was found to be statistically significant using Fisher's exact test (P<O.OOOl). Table 4 shows the percentage of cures in relationship to the specific features of the angioarchitecture.
Seven (8.8 %) of the 80 patients had complications as a result of embolisation (table 6) . Two of these patients had intracerebral haemorrhages: one ten hours and the other four days after the embolisations. One died as a result of the bleed accounting for the mortality of 1.2 % and the other patient completely recovered. Five patients developed non-haemorrhagic neurological deficits either immediately following the embolisation or up to 12 hours after the procedure. Four of the six patients made a complete recovery. Two patients were left with a disability accounting for a permanent morbidity of 2.5%. One was minor and she was able to return to work. The other was left with a moderate disability. Four patients had "glued" catheters that could not be removed from the vascular system but none caused any morbidity.
There were no complications related to embolisation of AVMs with angioarchitecture scores of 0-2. Five of the seven patients who had complications had AVMs with high (5-6) angioarchitecture scores (table 6) .
Five of the seven patients who had complications had Spetzler-Martin grade III AVMs and two were grade Il (table 5) . There were no complications in the grade I patients. There was no permanent morbidity or mortality in the Spetzler-Martin grades I or Il AVMs. Three of seven complications occurred in thalamic AVMs, including the two patients with permanent morbidity and mortality. This represented 50% of the thalamic AVMs in our series. Two were due to inadvertent occlusion of perforators to the internal capsule resulting in strokes. One resulted from venous penetration of the embolic material into the vein of Galen followed by an early post embolisation haemorrhage.
Discussion
The controversy regarding treatment of small AVMs has been between surgery and RS. Surgical cure rates range from 94-98% 10,11. Schaller et Al reported that 27.4% had neurological morbidity related to surgery and perma-R. Willinsky nent neurological deficits persisted in 3.2% of patients 10. The proportion of patients with nonneurological morbidity from this series was 9.7%. RS results in a progressive obliteration of the AVM over a two to three year period. However, during this period, the AVM can still bleed. The annual bleeding rate during this latent period following RS varies from 3.0 to 4.8%, although in Pollock et AI's series, 7.7% bled in the first eight months 9,16,21 . Cure rates from RS, confirmed by angiography, range from 55-65% 22,23 . The most important factor for a cure is the size of the AVM 22. Higher cure rates from RS, in the range of 80% , are frequently quoted, however only 38 to 55% of the patients in these series have had angiographic follow-up 9,24,25 . Delayed radiation necrosis after RS can result in neurological deficits in three to 13 % of patients 5,22,25,26. Most of these deficits occur between six months and two years following RS, although Yamamoto et al. reported two patients (5.3%) who had symptomatic radiation necrosis five and seven years post RS 22 . Porter et Al used a decision analysis model to conclude that surgery of small AVMs achieved a better clinical outcome, compared to RS, as long as the rate of permanent neurological morbidity from surgery did not exceed 12 % and surgical mortality did not exceed 4% 13 . Embolisation of brain AVMs is often an adjunctive therapy to be followed by surgery or RS 15-20. In most series, cure rates from embolisation have ranged from 11-15% with a permanent procedural morbidity from 6-14% and a mortality from 0-1.6% 15-20.27-29 . In Valavanis et AI's review of their own series, 158 (41 %) of 387 AVMs were completely obliterated by embolisation 29 . In the series by Wickholm et Al ten out of 14 AVMs with a volume of less than 4 cc were completely obliterated by embolisation 20. In Gobin et AI's series 31 % of the small AVMs were cured by embolisation 16. In our series, the goals of embolisation were cure, presurgical, preradiosurgery and elimination of an aneurysm. In 27 A VMs the goal of embolisation was cure. Nineteen (70%) of the 27 AVMs were completely obliterated by embolisation alone. In six of the remaining eight AVMs we achieved a 66-99% size reduction. The cure rate from embolisation when the goal was cure is comparable to RS but has the advantage of providing an immediate protection from bleeding.
In theory, size reduction of an AVM should be a useful adjunct to RS since smaller volume AVMs are more likely to be obliterated by RS 23,25. Friedman et Al achieved a complete obliteration with RS in 81 % of AVMs between 1 and 4 cc in volume, 89% of AVMs between 4 and 10 cc in volume and 69% of AVMs greater than 10 cc in volume 25. Pollock et Al found that smaller AVM size correlated with successful RS but found that embolisation before RS was a negative predictor for successful RS 23 . This apparent dichotomy can be explained by the fact that their patients had been embolised with particles that are well known to recanalize. Recanalization can occur with liquid adhesives (NBCA). The apparent "cure" results from proximal occlusion of the feeding arteries with little or no penetration into the nidus and its junction with the draining veins 30 . At present there is no proof indicating that AVMs made smaller by embolisation are more likely to be cured by RS compared to AVMs treated only byRS.
Retrospective studies have correlated the presence of aneurysms and venous stenosis to presentation with haemorrhage 31-34. Prospectively, patients with arterial aneurysms associated with AVMs have been found to have a higher annual risk of bleeding, from 5% to 9%, irrespective of their presentation 35. In this report, embolisation was successful in eliminating prenidal aneurysms in all five patients where this was the primary goal.
The angioarchitecture of an AVM has been an important factor in deciding whether embolisation should be considered. Embolisation of AVMs with direct dominant feeders and the pure arteriovenous fistulas have had favorable outcomes 29. Outcome from embolisation of AVMs with "en passage" arterial feeders and 29. In this report, we graded the AVMs based on the angioarchitecture and correlated the angioarchitecture score to the angiographic obliteration achieved by embolisation (table 3) . We found a statistically significant correlation (P<O.OOOl) between the angioarchitecture grade and the angiographic obliteration. In AVMs with angioarchitecture scores of 0-2, we had a cure rate of 86%, which is better than RS and begins to compare favorably to the high cure rates of surgery.
Analysis of the individual features of the angioarchitecture gives us further insight into which cases could be selected for embolisation (table 4). All five pure AVFs were cured. Fifteen (83 %) of the 18 AVMs with a dominant, single, pial arterial feeder were cured by embolisation. Previous reports on embolisation have found a positive correlation between a higher percentage of angiographic obliteration and a smaller number of feeding arteries 15 .1 6 • In Fournier et AI's report, cures were limited to AVMs with supply from only one arterial group (i.e. middle cerebral artery) 15 . In Gobin et AI's series complete occlusion was obtained by embolisation in 33 % of AVMs fed by a single artery decreasing in a linear fashion to 3 % if there were more than three feeding arteries 16 . Table 4 highlights the steep decline in cure rates in AVMs with angioarchitecture features other than the pure AVFs and the single, pial arterial feeders. In those AVMs with multiple feeding arteries the cure rate was only 11 %. The presence of feeding arterial perforators or choroidal supply also correlated with a low cure rate (10%). The cure rate of micro-arteriovenous malformations « 1 cm) was 47% compared to the low cure rate in 1-3 cm AVMs. There was a minimal difference in the cure rates between those AVMs with a single vein compared to those with multiple draining veins. Table 5 shows some correlation between the Spetzler-Martin grade and cure by embolisation with a higher percentage of cures in the lower grades (40% for grade I, 37% for grade Il, 10% for grade Ill). This correlation was much less striking than the correlation between cure rates and angiographic scores (86% in scores 0-2, 34 % in scores 3-4, 4 % in scores 5-6) (table 3). Even with the pure arteriovenous fistula removed from our analysis there was still a cure rate of 78% (7 of 9 AVMs) in AVMs with angioarchitecture scores of 0-2. In this review, the angioarchitecture score turned out to be a better predictor of angiographic obliteration than the Spetzler-Martin grading system.
In this report embolisation resulted in a 5.0% transient morbidity, 2.5% permanent morbidity and 1.2% mortality ( Reports by Gobin et Al and Wikholm et al. on embolisation of brain AVMs had a high percentage (85-90%) of Spetzler-Martin grades III -VI and therefore cure rates by embolisation alone in these series are low (10-13 %) 16,20 . Many of these patients were embolised for size reduction before RS and therefore nidus penetration was the goal in most cases. Embolisation in these series resulted in a 1.3 to 1.6% mortality and 6.7 to 7.2% moderate-to-severe morbidity 16,20 . In contrast, presurgical embolisation requires only closure of the feeding arteries. Closure of the feeding pedicle only reduces the risk of embolisation by avoiding venous penetration, which is a risk factor for early post embolisation haemorrhages. Venous penetration of the embolic material accounted for three of our seven complications and two of these were bleeds (table 6). In our 23 patients where the goal was a presurgical embolisation, we had one complication that was related to venous penetration. This complication occurred in 1993. Since that time we have realized that presurgical embolisation should be simple arterial "ligations" to avoid the risk of venous penetration. In addition, our surgeons prefer not to have the embolic material in the nidus since it interferes with their ability to do the dissection.
Limitations of the Study
This series spans one and a half decades and thus reflects a number of philosophies as our management strategy evolved. Twenty-three patients had pre-surgical embolisation targeting specific feeding arteries that were not easily accessible during the operation. Twenty-six patients had pre-radiosurgery embolisation for size reduction. The first four years of this study included 12 patients, whereas 61 patients were treated from 1989 to 1994. From 1995 to 1999, only seven patients with small AVMs were embolised. The increased activity in the second period reflected the burgeoning number of referrals and to some extent the development of flow-guided microcatheters. By 1995 our treatment paradigm shifted towards achieving a predictable cure. Early in our experience we had hoped that partial treatment would have some protective effect against bleeding. In Porter et AI's review of partially treated AVMs the annual bleeding rate after any type of treatment was similar, at approximately 3.4%, comparable to the natural history of AVMs 36.
Our Present Treatment Strategy
Our embolisation results have helped focus our decision-making for management of small AVMs. For AVMs with angioarchitecture scores of 0-2, embolisation has advantages over RS. The cure rate with embolisation is competitive to RS or even better if we compare to RS series with proven angiographic cures 23,25. Embolisation offers the advantage of immediate protection. Compared to surgery, the cure rates are lower with a similar morbidity 8,1O,1l . In small AVMs that are favorable for surgery, surgery is currently our preferred treatment except in the pure arteriovenous fistula where embolisation has proven to be effective.
For AVMs with angioarchitecture scores of 3-6 that are not favorable for surgery due to location or angioarchitecture, targeted embolisation to treat aneurysms can be justified before RS 17 . Presurgical embolisation of small AVMs is recommended in a limited number of patients where specific arteries will not be encountered till late in the dissection.
Conclusions
Embolisation is an effective treatment of small AVMs when the angioarchitecture is favorable (scores 0-2). Favorable angioarchitecture includes the pure fistulas and AVMs with a single, dominant, pial, feeding artery. In surgically accessible small AVMs we currently favor 
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